 |
| |
|
| CENTRE
UNIVERSITAIRE HOSPITALIER DE BESANCON |
|
 |
|
|
|
|
|
 |
|
|
|
| |
Balkau
B, Deanfield JE, Després JP, Bassand
JP, Fox KA, Smith SC Jr, Barter P, Tan
CE, Van Gaal L, Wittchen HU, Massien
C, Haffner SM.
International Day for the Evaluation of Abdominal Obesity (IDEA): a
study of waist circumference, cardiovascular disease, and diabetes
mellitus in 168,000 primary care patients in 63 countries.
Circulation. 2007 ;116:1942-51.
|
| |
Bassand
JP, Richard-Lordereau I, Cadroy Y.
Efficacy and safety of fondaparinux in patients with acute coronary
syndromes.
Expert Rev Cardiovasc Ther. 2007 ;5:1013-26
|
| |
Bassand
JP, Hamm CW, Ardissino D, Boersma E,
Budaj A, Fernandez-Aviles F, Fox KA,
Hasdai D, Ohman EM, Wallentin L, Wijns
W.
Task Force per la
Diagnosi e il Trattamento delle Sindromi
Coronariche; Acute Senza Sopraslivellamento
del Tratto ST della Società Europea;
di Cardiologia.
[Tradotto da guidelines
for the diagnosis and treatment of non-ST-segment
elevation acute coronary syndromes.
The Task Force for the Diagnosis and
Treatment of non-ST-Segment Elevation
Acute Coronary Syndromes of the European
Society of Cardiology]
G Ital Cardiol (Rome). 2007 ;8:599-675.
|
| |
Mehta SR, Granger CB, Eikelboom JW, Bassand JP, Wallentin L, Faxon DP,
Peters RJ, Budaj A, Afzal R, Chrolavicius S, Fox KA, Yusuf S.
Efficacy and safety of fondaparinux versus enoxaparin in patients with
acute coronary syndromes undergoing percutaneous coronary intervention:
results from the OASIS-5 trial.
J Am Coll Cardiol. 2007 ;50:1742-51.
|
| |
Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés
F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W.
[ESC 2007 Guidelines for the diagnosis and treatment of non-ST-segment
elevation acute coronary syndromes]
Rev Esp Cardiol. 2007 ;60:1070.e1-80.
|
| |
Fox KA, Bassand JP, Mehta SR, Wallentin L, Theroux P, Piegas LS,
Valentin V, Moccetti T, Chrolavicius S, Afzal R, Yusuf S; OASIS 5
Investigators.
Influence of renal function on the efficacy and safety of fondaparinux
relative to enoxaparin in non ST-segment elevation acute coronary syndromes.
Ann Intern Med. 2007 ;147:304-10.
|
| |
Bassand JP.
Impact of anaemia,
bleeding, and transfusions in acute
coronary syndromes: a shift in the paradigm.
Eur Heart J. 2007
May 5; [Epub ahead of print] .
|
| |
Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP.
Bleeding and blood
transfusion issues in patients with
non-ST-segment elevation acute coronary
syndromes.
Eur Heart J. 2007;28:1193-204 |
| |
Schiele
F, Seronde MF, Descotes-Genon V, Blonde
MC, Legalery P, Meneveau N, Ecarnot
F, Penfornis A, Ducloux D, Bassand JP.
Impact of renal dysfunction
and glucometabolic status on one month
mortality after acute myocardial infarction.
Acute Card Care. 2007;9:34-42
|
| |
Deschaseaux
F, Selmani Z, Falcoz PE, Mersin N, Meneveau
N, Penfornis A, Kleinclauss C, Chocron
S, Etievent JP, Tiberghien P, Kantelip
JP, Davani S.
Two types of circulating
endothelial progenitor cells in patients
receiving long term therapy by HMG-CoA
reductase inhibitors.
Eur J Pharmacol. 2007;562:111-8
|
| |
Tsuchida
K, Serruys PW, Bruining N, Dudek D,
Drzewiecki J, Banning AP, Zmudka K,
Schiele F, Zhou Z, Rademaker TA, van
Es GA, Koglin J, Russell ME, Colombo
A.
Two-Year
Serial Coronary Angiographic and Intravascular
Ultrasound Analysis of In-Stent Angiographic
Late Lumen Loss and Ultrasonic Neointimal
Volume from the TAXUS II Trial.
Am J Cardiol. 2007
Mar 1;99(5):607-15. Epub 2007 Jan 9.
|
| |
Wei
H, Schiele F, Meneveau N, Seronde MF,
Legalery P, Bonneville JF, Chocron S,
Bassand JP.
Potential
interest of intra-aorta ultrasound imaging
for the diagnosis
of aortic penetrating atherosclerotic
ulcer.
Int J Cardiovasc
Imaging. 2006;22:653-6
|
| |
Bassand
JP.
Managing
cardiovascular risk in patients with
metabolic syndrome.
Clin
Cornerstone. 2006;8 Suppl 1:S7-14.
|
| |
Sleight
P, Eikelboom JW, Bassand JP.
Enoxaparin versus
unfractionated heparin in ST-elevation
myocardial infarction.
N
Engl J Med. 2006 Jun 29;354(26):2830-1
|
| |
Bassand
JP, Danchin N, Filippatos G, Gitt A,
Hamm C, Silber S, Tubaro M, Weidinger
F.
[Reperfusion
treatment of acute myocardial infarct.
Guidelines of European Cardiological
Society]
Kardiol
Pol. 2006 Feb;64(2):161-72
|
| |
Clearfield
MB, Amerena J, Bassand JP, Garcia HR,
Miller SS, Sosef FF, Palmer MK, Bryzinski
BS..
Comparison of the
efficacy and safety of rosuvastatin
10 mg and atorvastatin 20 mg in high-risk
patients with hypercholesterolemia -
Prospective study to evaluate the Use
of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR).
Trials. 2006 ;7:35
|
| |
Schiele
F, Descotes-Genon V, Seronde MF, Blonde
MC, Legalery P, Meneveau N, Ecarnot
F, Mercier M, Penfornis A, Thebault
L, Boumal D, Bassand JP; on behalf of
the investigators of the Reseau Franc
Comtois de Cardiologie.
Predictive
value of admission hyperglycaemia on
mortality in patients with acute myocardial
infarction.
Diabet
Med. 2006 Dec;23(12):1370-6.
|
| |
Yusuf
S, Mehta SR, Chrolavicius S, Afzal R,
Pogue J, Granger CB, Budaj A, Peters
RJ, Bassand JP, Wallentin L, Joyner
C, Fox KA; OASIS-6 Trial Group.
Effects of Fondaparinux
on Mortality and Reinfarction in Patients
With Acute ST-Segment Elevation Myocardial
Infarction: The OASIS-6 Randomized Trial.
JAMA. 2006 Apr
5;295(13):1519-30. Epub 2006 Mar 14.
|
| |
Yusuf
S, Mehta SR, Chrolavicius S, Afzal R,
Pogue J, Granger CB, Budaj A, Peters
RJ, Bassand JP, Wallentin L, Joyner
C, Fox KA; Fifth Organization to Assess
Strategies in Acute Ischemic Syndromes
Investigators.
Comparison
of Fondaparinux and Enoxaparin in Acute
Coronary Syndromes
N
Engl J Med. 2006 Apr 6;354(14):1464-76.
Epub 2006 Mar 14.
|
| |
Schiele
F, Legalery P, Didier K, Meneveau N,
Seronde MF, Caulfield F, Ducloux D,
Bechetoille P, Magnin D, Faivre R, Bassand
JP.
Impact
of renal dysfunction on 1-year mortality
after acute myocardial infarction
Am Heart J.
2006 ;151:661-7
|
| |
Aoki
J, Colombo A, Dudek D, Banning AP, Drzewiecki
J, Zmudka K, Schiele F, Russell ME,
Koglin J, Serruys PW; TAXUS II Study
Group
Peristent
remodeling and neointimal suppression
2 years after polymer-based, paclitaxel-eluting
stent implantation: insights from serial
intravascular ultrasound analysis in
the TAXUS II study.
Circulation.
2005 Dec 20;112(25):3876-83. Epub 2005
Dec 12
|
| |
Bernard
Y.
[Value
of transoesophageal echocardiography
for the diagnosis of embolic lesions
from the thoracic aorta] J Neuroradiol.
2005 Sep;32(4):266-72. Review. French.
|
| |
Schiele F:
[Chronic
renal failure: an independent factor
of mortality after myocardial infarction]
Ann Cardiol
Angeiol (Paris). 2005 Aug;54(4):161-7.
French |
| |
Bassand
JP, Danchin N, Filippatos G, Gitt A,
Hamm C, Silber S, Tubaro M, Weidinger
F.
Implementation
of reperfusion therapy in acute myocardial
infarction. A policy statement from
the European Society of Cardiology.
Eur Heart J.
2005 Dec;26(24):2733-41. Epub 2005 Nov
25.
|
| |
Mukherjee
D, Topol EJ, Bertrand ME, Kristensen
SD, Herrmann HC, Neumann FJ, Yakubov
SJ, Bassand JP, McClure RR, Stone GW,
Ardissino D, Moliterno DJ.
Mortality at
1 year for the direct comparison of
tirofiban and abciximab during percutaneous
coronary revascularization: do tirofiban
and ReoPro give similar efficacy outcomes
at trial 1-year follow-up.
Eur
Heart J. 2005 Dec;26(23):2524-8. Epub
2005 Aug 17.
|
|
Legalery
P, Schiele F, Seronde MF, Meneveau N,
Wei H, Didier K, Blonde MC, Caulfield
F, Bassand JP.
One-year
outcome of patients submitted to routine
fractional flow reserve assessment to
determine the need for angioplasty.
Eur Heart J.
2005 Dec;26(24):2623-9. Epub 2005 Sep
1.
|
|
Bassand
JP, Priori S, Tendera M.
*Evidence-based
vs. 'impressionist' medicine: how best
to implement guidelines.*
Eur
Heart J. 2005 Jun;26(12):1155-8. Epub
2005 May 3.
|
|
Schiele
F, Meneveau N, Seronde MF, Caulfield
F, Fouche R, Lassabe G, Baborier D,
Legalery P, Bassand JP.
**Compliance
with guidelines and 1-year mortality
in patients with acute myocardial infarction:
a prospective study.*
Eur
Heart J. 2005 Jan 28; [Epub ahead of
print]
|
|
Mehta
SR, Steg PG, Granger CB, Bassand JP,
Faxon DP, Weitz JI, Afzal R, Rush B,
Peters RJ, Natarajan MK, Velianou JL,
Goodhart DM, Labinaz M, Tanguay JF,
Fox KA, Yusuf S; ASPIRE Investigators.
* Randomized,
blinded trial comparing fondaparinux
with unfractionated heparin in patients
undergoing contemporary percutaneous
coronary intervention: Arixtra Study
in percutaneous Coronary Intervention:
a Randomized Evaluation (ASPIRE) Pilot
Trial.
Circulation.
2005 Mar 22;111(11):1390-7.
|
|
Hoen
B, Chirouze C, Cabell CH, Selton-Suty
C, Duchene F, Olaison L, Miro JM, Habib
G, Abrutyn E, Eykyn S, Bernard Y, Marco
F, Corey GR; International Collaboration
on Endocarditis Study Group.
Emergence of
endocarditis due to group D streptococci:
findings derived from the merged database
of the International Collaboration on
Endocarditis.
Eur
J Clin Microbiol Infect Dis. 2005 Jan;24(1):12-6.
|
|
Argaud
L, Rioufol G, Lievre M, Bontemps L,
Legalery P, Stumpf M, Finet G, Itti
R, Andre-Fouet X, Ovize M.
Preconditioning
during coronary angioplasty: no influence
of collateral perfusion or the size
of the area at risk.
Eur
Heart J. 2004 ;25:2019-2025.
|
|
Kastler
B, Livolsi A, Germain P, Bernard Y,
Michalakis D, Rodiere E, Louis G, Litzler
JF, Vignaux O.
[Value
of MRI in the evaluation of congenital
anomalies of the heart and great vessels]
J Radiol. 2004 Oct;85(10 Pt 2):1821-50.
Review. French.
J
Radiol. 2004 Oct;85(10 Pt 2):1821-50.
Review. French.
|
|
Duval
X, Selton-Suty C, Alla F, Salvador-Mazenq
M, Bernard Y, Weber M, Lacassin F, Nazeyrolas
P, Chidiac C, Hoen B, Leport C; Association
pour l'Etude et la Prevention de l'Endocardite
Infectieuse.
Endocarditis
in patients with a permanent pacemaker:
a 1-year epidemiological survey on infective
endocarditis due to valvular and/or
pacemaker infection.
Clin
Infect Dis. 2004 Jul 1;39(1):68-74.
Epub 2004 Jun 14.
|
|
Magy
N, Gil H, Meaux-Ruault N, Bernard Y,
Etievent JP, Roncato M, Hafsaoui C,
Dupond JL.
[The
butcher was sad a heart!...]
Rev
Med Interne. 2004 Jun;25 Suppl 2:S221-3.
French. No abstract available.
|
|
Schiele
F.
[Predictive
factors of restenosis: what changes
with " active " stents?]
Pathol Biol
(Paris). 2004 ;52:206-211.
|
|
Limat
S, Demesmay K, Voillat L, Bernard Y,
Deconinck E, Brion A, Sabbah A, Woronoff-Lemsi
MC, Cahn JY.
Early
cardiotoxicity of the CHOP regimen in
aggressive non-Hodgkin's lymphoma.
Ann Oncol. 2003;14:277-81.
|
|
Bassand
JP.
Welcome.
J Cardiovasc
Risk. 2003 ;10:233.
|
|
Priori
SG, Klein W, Bassand JP; ESC Committee
for Practice Guidelines 2002-2004
Medical Practice
Guidelines. Separating science from
economics.
Eur
Heart J. 2003;24:2237-8.
|
|
Bassand
JP.
The
relations between the ESC and the European
Union. Major initiatives to come in
health and cardiovascular research.
Eur Heart J.
2003;24:2237-8.
|
|
Haager
PK, Schiele F, Buettner HJ, Garcia E,
Bedossa M, Mudra H, Dietz U, Di Mario
C, Reineke T, Horn B, Hoffmann R, Radke
PW, Klues HG, Vom Dahl J.
Insufficient
tissue ablation by rotational atherectomy
leads to worse long-term results in
comparison with balloon angioplasty
alone for the treatment of diffuse in-stent
restenosis: Insights from the intravascular
ultrasound substudy of the ARTIST randomized
multicenter trial.
Catheter
Cardiovasc Interv. 2003;60:25-31.
|
|
Colombo
A, Drzewiecki J, Banning A, Grube E,
Hauptmann K, Silber S, Dudek D, Fort
S, Schiele F, Zmudka K, Guagliumi G,
Russell ME; TAXUS II Study Group.
Randomized study
to assess the effectiveness of slow-
and moderate-release polymer-based paclitaxel-eluting
stents for coronary artery lesions.
Circulation
2003;108:788-94.
|
|
Kelley
MP, Klugherz BD, Hashemi SM, Meneveau
NF, Johnston JM, Matthai WH, Banka VS,
Herrmann HC, Hirshfeld JW, Kimmel SE,
Kolansky DM, Horwitz PA, Schiele F,
Bassand JP, Wilensky RL.
One-year
clinical outcomes of protected and unprotected
left main coronary artery stenting.
Eur Heart J.
2003 ;24:1554-9.
|
|
Meneveau
N, Ming LP, Seronde MF, Mersin N, Schiele
F, Caulfield F, Bernard Y, Bassand JP.
In-hospital
and long-term outcome after sub-massive
and massive
pulmonary embolism submitted to thrombolytic
therapy.
Eur
Heart J. 2003 ;24:1447-54.
|
|
Bassand JP, Berthe C, Bethencourt
A, Bolognese L, Wojcik J.
Safety of percutaneous coronary
interventions in patients receiving
nadroparin calcium for unstable angina
or non-Q-wave myocardial infarction.
The ANGIOFRAX study.
Curr
Med Res Opin 2003;19:107-113.
|
|
Legalery P, Seronde MF, Meneveau N,
Schiele F, Bassand JP.
Measuring
pressure-derived fractional flow reserve
through four French diagnostic catheters
Am J Cardiol
2003;91:1075-8.
|
|
Bassand JP.
Classification
des Syndromes Coronaires Aigus
La
Revue du Praticien 2003;53:597
|
|
Liu
P, Meneveau N, Schiele F, Bassand JP.
Long-term outcome
of acute massive pulmonary thromboembolism
following thrombolysis.
Zhonghua
Nei Ke Za Zhi. 2002 Nov;41(11):750-
3
|
|
Schiele
F, Meneveau N, Gilard M, Boschat J,
Commeau P, Ming LP, Sewoke P, Seronde
MF, Mercier M,Gupta S, Bassand JP.
Intravascular
Ultrasound-Guided Balloon Angioplasty
Compared With Stent:
Immediate
and 6-Month Results of the Multicenter,
Randomized Balloon Equivalent to Stent
Study (BEST).
Circulation
2003;107:545-51
|
|
Bassand
JP, Martin J, Ryden L, Simoons M.
The need for
resources for clinical research: the
European Society of Cardiology calls
for European, international collaboration.
Lancet 2002;360:1866-1869
|
|
Mauri
L, Bonan R, Weiner BH, Legrand V, Bassand
JP, Popma JJ, Niemyski P, Prpic R, Ho
KK, Chauhan MS, Cutlip DE, Bertrand
OF, Kuntz RE.
Cutting
balloon angioplasty for the prevention
of restenosis: results of the Cutting
Balloon Global Randomized Trial.
Am J Cardiol
2002;90:1079-83
|
|
Meneveau
NF, Klugherz BD, Chaqour B, Anand V,
Tomaszewski JE, Joullie MM, Macarak
E, Golden M, Weisz PB, Wilensky RL.
Beta-cyclodextrin
tetradecasulfate, a novel cyclic oligosaccharide,
inhibits thrombus and neointimal formation
after coronary vascular injury.
Coron Artery
Dis. 2002;13:189-97
|
|
Simoons
ML, van der Putten N, Wood D, Boersma
E, Bassand JP.
The
Cardiology Information System: the need
for data standards for integration of
systems for patient care, registries
and guidelines for clinical practice.
Eur Heart J
2002 ;23:1148-52
|
|
Moliterno
DJ, Yakubov SJ, DiBattiste PM, Herrmann
HC, Stone GW, MacayaC, Neumann FJ, Ardissino
D, Bassand JP, Borzi L, Yeung AC, Harris
KA,Demopoulos LA, Topol EJ, for the
TARGET Investigators.
Outcomes
at 6 months for the direct comparison
of tirofiban and abciximab during percutaneous
coronary revascularisation with stent
placement: the TARGET follow-up study.
Lancet 2002;360:355-60
|
|
Bassand
JP.
[Platelet
Antiaggregation Treatment in the Aftermath
of GUSTO IV,TARGET, TACTICS, and CURE
Trials]
Rev
Esp Cardiol. 2002;55:697-702. In Spanish
|
|
Antman
EM, Louwerenburg HW, Baars HF, Wesdorp
JCL, Hamer B, Bassand JP, Bigonzi F,
Pisapia G, Gibson CM, Heidbuchel H,
Braunwald E, Van de Werf F
Enoxaparin
as adjunctive antithrombin therapy for
ST-elevation
myocardial infarction. Results of the
ENTIRE-Thrombolysis in Myocardial
Infarction (TIMI)
23 Trial.
Circulation
2002;105:1642-9
|
|
vom
Dahl J, Dietz U, Haager PK, Silber S,
Niccoli L, Buettner HJ,
Schiele F, Thomas M, Commeau P, Ramsdale
DR, Garcia E, Hamm CW, Hoffmann R, Reineke
T, Klues HG, for the ARTIST Investigators
Rotational atherectomy
does not reduce recurrent in-stent restenosis.
Results of the
Angioplasty Versus Rotational Atherectomy
for Treatment
of Diffuse In-Stent Restenosis Trial
(ARTIST)
Circulation
2002;105:583-588
|
|
Papavero
R, Kastler B, Clair C, Litzler J, Delabrousse
E, Livolsi A, Scheneider P, Site O,
Bernard Y.
[Thoracic
aortic coarctation: MRI evaluation and
follow-up]
J
Radiol. 2001 ;82:555-61
|
|
Bassand
JP
Situation
de la recherche clinique en France
Arch Mal Coeur
Vaiss 2001;94:1139-40 - In French 
|
|
Zhang
D, Cai X, Shen W, Schiele F, Bassand
JP.
Intracoronary
stent implantation under intracoronary
ultrasound guidance with aspirin and
ticlopidine therapy.
Chin
Med J (Engl) 2001;114:262-5
|
|
Penfornis
A, Zimmermann C, Boumal D, Sabbah A,
Meneveau N, Gaultier-Bourgeois S, Bassand
JP, Bernard Y.
Use
of dobutamine stress echocardiography
in detecting silent myocardial ischaemia
in asymptomatic diabetic patients: a
comparison with thallium scintigraphy
and exercise testing.
Diabet
Med 2001;18:900-905.
|
|
Ryden
L, Simoons ML, Bassand JP.
Partnership
in cardiovascular medicine. A key to
success not only for professional organizations.
Eur Heart J
2001;22:1839-4
3
|
|
Coussement
PK, Bassand JP, Convens C, Vrolix M,
Boland J, Grollier G, Michels R, Vahanian
A, Vanderheyden M, Rupprecht HJ, van
de Werf F; for the PENTALYSE investigators
A synthetic
factor-Xa inhibitor (ORG31540/SR9017A)
as an adjunct to fibrinolysis in acute
myocardial infarction. The PENTALYSE
study.
Eur
Heart J 2001;22:1716-1724
|
|
Bernard
Y, Zimmermann H, Chocron S, Litzler
J, Kastler B, Etievent J, Meneveau N,
Schiele F, Bassand J.
False
lumen patency as a predictor of late
outcome in aortic dissection.
Am
J Cardiol 2001 Jun 15;87:1378-82
|
|
Schiele
F.
Intravascular
ultrasound guidance for stent implantation.
Circulation.
2001 May 29;103:E110-0. No abstract
available.
|
|
Bernard
Y, Meneveau N, Boucher S, Magnin D,
Anguenot T, Schiele F, Vuillemenot A,
Bassand JP.
Lack
of agreement between left ventricular
volumes and ejection fraction determined
by two-dimensional echocardiography
and contrast cineangiography in postinfarction
patients.
Echocardiography.
2001 Feb;18:113-22
.
|
|
Bassand
JP.
Low-molecular-weight
heparin and other antithrombotic agents
in the setting of a fast-track revascularization
in unstable coronary artery disease.
Haemostasis.
2000 Mar;30 Suppl S2:114-21.
|
|
Schiele
F, Batur MK, Seronde MF, Meneveau N,
Sewoke P, Bassignot A, Couetdic G, Caulfield
F, Bassand JP.
Cytomegalovirus,
Chlamydia pneumoniae, and Helicobacter
pylori IgG antibodies and restenosis
after stent implantation: an angiographic
and intravascular ultrasound study.
Heart. 2001
Mar;85:304-311.
|
|
Delabrousse
E, Kastler B, Bernard Y, Couvreur M,
Clair C. Related Articles, Links
MR diagnosis
of a congenital abnormality of the thoracic
aorta with an aneurysm of the right
subclavian artery presenting as a Horner's
syndrome in an adult.
Eur
Radiol. 2000;10:650-2
|
|
Schiele
F, Bassand JP.
OPUS and routine angiography
Lancet
2000 ; 356 : 1524.
|
|
Meneveau
N, Schiele F, Grollier G, Farah B,Lablanche
JM, Khalifé K, Machecourt J,
Danchin N, Wolf JE, Simpson M, Hak JB,
Bassand JP.
Local
Delivery of Nadroparin for the Prevention
of Neointimal Hyperplasia Following
Stent Implantation : Results of the
IMPRESS Trial.
Eur
Heart J. 2000 ; 21 : 1767-1775
.
|
|
Bassand
JP.
Improving
the quality and dissemination of guidelines
: the quest for the Holy Grail.
Eur Heart J
2000 ; 21 : 1289-1290.
|
|
Klugherz
BD, Meneveau NF, Kolansky DM, Herrman
HC, Schiele F, Matthai WH, Groh WC,
Untereker WJ, Hirshfeld JW, Bassand
JL, Wilensky RL.
Predictors
of clinical outcome following percutaneous
intervention for in-stent restenosis.
Am J Cardiol
2000 ; 85 : 1427-1431.
|
|
Bassand
JP.
La
commissurotomie mitral percutanée
: fin de partie pour le ballon? (Editorial)
Arch Mal Coeur
Vaiss. 2000 ; 93 : 681-2. In French
|
|
Schiele
F, Meneveau N, Seronde MF, Deforet MF,
Gupta S, Bassand JP.
Predictors
of event-free survival after repeat
intracoronary procedure for in-stent
restenosis. Study with angiographic
and intravascular ultrasound imaging.
Eur Heart J
2000 ; 21 : 754-62.
|
|
Bassand
JP.
Intravascular
ultrasound guided PTCA : a way to escape
stent mania?
Eur
Heart J. 2000 ; 21 : 92-94.
|
|
Bassand
JP.
[Angioplasty
in unstable chest angina. Angioplasty
in unstable angina].
Arch
Mal Coeur Vaiss. 1999 ; 92 : 1609-15.
|
|
Malergue
MC, Abergel E, Bernard Y, Bruntz JF,
Chauvel C, Cohen A, Cormier B, Tribouilloy
C.
[Recommendations
of the French Society of Cardiology
concerning indications for Doppler echocardiography].
Arch Mal Coeur
Vaiss. 1999 ; 92 : 1347-79.
|
|
Bassand
JP, Ryden L.
Guidelines
: making the headlines or confined to
the sidelines?
Eur
Heart J. 1999 ; 20 : 1149-51.
|
|
Bernard
Y.
[Aortic
stenosis : etiology, physiopathology,
diagnosis, course].
Rev
Prat. 1999 ; 49 : 1091-6.
|
|
Bassand
JP, Cariou R, Grollier G, Kragten J,
Wolf JE, Heyndrickx GR.
Clopidogrel-rt-PA-heparin
combination in the treatment of acute
myocardial infarction.
Semin
Thromb Hemost. 1999 ; 25 Suppl 2 : 69-75.
|
|
Schiele
F, Vuillemot A, Meneveau N, Pales-Espinosa
D, Gupta S, Bassand JP.
Effects
of increasing balloon pressure on mechanism
and results of balloon angioplasty for
treatment of restenosis after Palmaz-Schatz
stent implantation : an angiographic
and intravascular ultrasound study.
Catheter
Cardiovasc Interv. 1999 ; 46 : 314-21.
|
|
Vuillemenot
A, Schiele F, Meneveau N, Claudel S,
Donat F, Fontecave S, Cariou R, Samama
MM, Bassand JP.
Efficacy
of a synthetic pentasaccharide, a pure
factor Xa inhibitor, as an antithrombotic
agent--a pilot study in the setting
of coronary angioplasty.
Thromb
Haemost. 1999 ; 81 : 214-20.
|
|
Meneveau
N, Schiele F, Seronde MF, Breton V,
Gupta S, Bernard Y.
Predictors
of event-free survival after percutaneous
mitral commissurotomy.
Heart.
1998 ; 80 : 359-64.
|
|
Gupta
S, Schiele F, Vuillemenot A, Appfel
F, Bassand JP.
Coronary
stent for variant angina : atypical
presentation.
Cathet
Cardiovasc Diagn. 1998 ; 45 : 439-41.
|
|
Garbarz
E, Farah B, Vuillemenot A, Andre F,
Angioi M, Machecourt J, Bassand JP,
Wolf JE, Danchin N, Prendergast BIung
B, Vahanian A.
"Rescue"
abciximab for complicated percutaneous
transluminal coronary angioplasty.
Am J Cardiol.
1998 ; 82 : 800-3, A9.
|
|
Schiele
F, Meneveau N, Vuillemenot A, Zhang
DD, Gupta S, Mercier M, Danchin N, Bertrand
B, Bassand JP.
Impact
of intravascular ultrasound guidance
in stent deployment on 6-month restenosis
rate : a multicenter, randomized study
comparing two strategies--with and without
intravascular ultrasound guidance. RESIST
Study Group. REStenosis after Ivus guided
Stenting.
J
Am Coll Cardiol. 1998 ; 32 : 320-8.
|
|
Schiele
F, Meneveau N, Vuillemenot A, Gupta
S, Bassand JP.
Treatment
of in-stent restenosis with high speed
rotational atherectomy and IVUS guidance
in small <3.0 mm vessels.
Cathet
Cardiovasc Diagn. 1998 ; 44 : 77-82.
|
|
Gupta
S, Schiele F, Xu C, Meneveau N, Seronde
MF, Breton V, Bernard Y, Bassand JP.
Simplified
percutaneous mitral valvuloplasty with
the Inoue balloon.
Eur
Heart J. 1998 ; 19 : 610-6.
|
|
Meneveau
N, Schiele F, Metz D, Valette B, Attali
P, Vuillemenot A, Grollier G, Elaerts
J, Mossard JM, Viel JF, Bassand JP.
Comparative
efficacy of a two-hour regimen of streptokinase
versus alteplase in acute massive pulmonary
embolism : immediate clinical and hemodynamic
outcome and one-year follow-up.
J Am Coll Cardiol.
1998 ; 31 : 1057-63.
|
|
Lablanche
JM, McFadden EP, Meneveau N, Lusson
JR, Bertrand B, Metzger JP, Legrand
V, Grollier G, Macaya C, de Bruyne B,
Vahanian A, Grentzinger A, Masquet C,
Wolf JE, Tobelem G, Fontecave S, Vacheron
A, d'Azemar P, Bertrand ME.
Effect of nadroparin,
a low-molecular-weight heparin, on clinical
and angiographic restenosis after coronary
balloon angioplasty : the FACT study.
Fraxiparine Angioplastie Coronaire Transluminale.
Circulation.
1997 ; 96 : 3396-402.
|
|
Bertrand
ME, McFadden EP, Fruchart JC, Van Belle
E, Commeau P, Grollier G, Bassand JP,
Machecourt J, Cassagnes J, Mossard JM,
Vacheron A, Castaigne A, Danchin N,
Lablanche JM.
Effect
of pravastatin on angiographic restenosis
after coronary balloon angioplasty.
The PREDICT Trial Investigators. Prevention
of Restenosis by Elisor after Transluminal
Coronary Angioplasty.
J
Am Coll Cardiol. 1997 ; 30 : 863-9.
|
|
Meneveau
N, Bassand JP, Bauters, Rozand JY, Petit
JL, Beurrier D, Grollier G, Andre F,
Vahanian A, Viel JF.
Influence
of late reopening of the infarct-related
artery on left ventricular remodelling
after myocardial infarction. IRIS Study
Group.
Eur
Heart J. 1997 ; 18 : 1261-8.
|
|
Cohen
A, Tzourio C, Chauvel C, Bertrand B,
Crassard I, Bernard Y, Goullard L, Falcon
S, Bousser MG, Amarenco P.
Mitral
valve strands and the risk of ischemic
stroke in elderly patients. The French
Study of Aortic Plaques in Stroke (FAPS)
Investigators.
Stroke.
1997 ; 28 : 1574-8.
|
|
Bernard
Y, Meneveau N, Vuillemenot, Magnin D,
Anguenot T, Schiele F, Bassand JP.
Planimetry of
aortic valve area using multiplane transoesophageal
echocardiography is not a reliable method
for assessing severity of aortic stenosis.
Heart. 1997
; 78 : 68-73.
|
|
Meneveau
N, Schiele F, Vuillemenot A, Valette
B, Grollier G, Bernard Y, Bassand JP.
Streptokinase
vs alteplase in massive pulmonary embolism.
A randomized trial assessing right heart
haemodynamics and pulmonary vascular
obstruction.
Eur
Heart J. 1997 ; 18 : 1141-8.
|
|
Laperche
T, Laurian C, Roudaut R, Steg PG.
Mobile thromboses
of the aortic arch without aortic debris.
A transesophageal echocardiographic
finding associated with unexplained
arterial embolism. The Filiale Echocardiographie
de la Societe Francaise de Cardiologie.
Circulation.
1997 ; 96 : 288-94.
|
|
Schiele
F, Lindgaerde F, Eriksson H, Bassand
JP, Wallmark A, Hansson PO, Grollier
G, Sjo M, Moia M, Camez A, Smyth V,
Walker M.
Subcutaneous
recombinant hirudin (HBW 023) versus
intravenous sodium heparin in treatment
of established acute deep vein thrombosis
of the legs : a multicentre prospective
dose-ranging randomized trial. International
Multicentre Hirudin Study Group.
Thromb Haemost.
1997 ; 77 : 834-8.
|
|
Bernard
Y.
[Heart
valve prosthesis. Monitoring, complications].
Rev Prat. 1997
; 47 : 427-34.
|
|
Lablanche
JM, Grollier G, Lusson JR, Bassand JP,
Drobinski G, Bertrand B, Battaglia S,
Desveaux B, Juilliere Y, Julliard JM,
Metzger JP, Coste P, Quiret JC, Dubois-Rande
JL, Crochet PD, Letac B, Boschat j,
Virot P, Finet G, Le Breton H, Livarek
B, Leclercq F, Beard T, Giraud T, Bertrand
ME, et al.
Effect
of the direct nitric oxide donors linsidomine
and molsidomine on angiographic restenosis
after coronary balloon angioplasty.
The ACCORD Study. Angioplastic Coronaire
Corvasal Diltiazem.
Circulation.
1997 ; 95 : 83-9.
|
|
Schiele
F, Vuillemenot A, Mouhat T, Kieffer
Y, Anguenot T, Bernard Y, Bassand JP.
[Anticoagulant
therapy with recombinant hirudin in
patients with thrombopenia induced by
heparin].
Presse
Med. 1996 ; 25 : 757-60.
|
|
Bernard
Y, Anguenot T, Meneveau N, Vuillemenot
A, Schiele F, Bassand JP.
[Long-term
outcome of subvalvular aortic stenoses.
A comparative study in adults and children].
Arch Mal Coeur
Vaiss. 1996 ; 89 : 579-85.
|
|
The
French Study of Aortic Plaques in Stroke
Group.
Atherosclerotic
disease of the aortic arch as a risk
factor for recurrent ischemic stroke.
The French Study of Aortic Plaques in
Stroke Group.
N
Engl J Med. 1996 ; 334 : 1216-21.
|
|
Meneveau
N, Vuillemenot A, Bassand JP.
[Complications
of thrombolytic therapy in pulmonary
embolism].
Arch
Mal Coeur Vaiss. 1995 ; 88 : 1769-76.
|
|
Vuillemenot
A, Meneveau N, Bassand JP.
[Severe
pulmonary embolism : value of clinical
findings and complementary investigations].
Arch Mal Coeur
Vaiss. 1995 ; 88 : 1745-54.
|
|
Bassand
JP, Vuillemenot A.
[Coronary
recanalization in the acute phase of
myocardial infarction].
Rev
Prat. 1995 ; 45 : 2137-44.
|
|
Mas
JL, Zuber M.
Recurrent
cerebrovascular events in patients with
patent foramen ovale, atrial septal
aneurysm, or both and cryptogenic stroke
| | | | | | |
